<DOC>
	<DOCNO>NCT01488071</DOCNO>
	<brief_summary>The objective present study evaluate whether vortioxetine ( 10 20 mg/day ) least effective agomelatine ( 25 50 mg/day ) patient depressive symptom show inadequate response Serotonin Reuptake Inhibitors ( SRI ) antidepressant .</brief_summary>
	<brief_title>A Study Vortioxetine ( Lu AA21004 ) Comparison Agomelatine Adults Suffering From Major Depression With Inadequate Response Previous Medication</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Vortioxetine</mesh_term>
	<mesh_term>S 20098</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>The patient treat serotonin reuptake inhibitor ( SRI ) antidepressant ( monotherapy ) prescribe treat Major Depressive Episode ( DSMIVTR criterion ) The response current SRI treatment inadequate patient agree discontinue current SRI baseline Montgomery Åsberg Depression Rating Scale ( MADRS ) total score ≥22 Screening Visit Baseline The patient , woman , must : agree try become pregnant study , AND use adequate , highly effective contraception The patient current Axis I disorder ( DSMIV criterion ) Major Depressive Disorder ( MDD ) , General Anxiety Disorder ( GAD ) Social Anxiety Disorder ( SAD ) The patient significant risk suicide The patient currently receive formal psychotherapy psychoactive medication Other protocoldefined inclusion exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Depression</keyword>
	<keyword>Multimodal antidepressant</keyword>
</DOC>